Cell & Gene Therapy Manufacturing Services Market Expansion Is Opening New Pathways For Strategic Investment
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cell & Gene Therapy Manufacturing Services Market Forecast: What Market Value Is Expected By 2030?
The market for cell and gene therapy manufacturing services is experiencing robust expansion. Projections indicate a rise from $9.44 billion in 2025 to $11.08 billion by 2026, reflecting a compound annual growth rate of 17.4%. Factors fueling this growth during the previous period include a rising tide of cell and gene therapy clinical candidates, the early adoption of manufacturing service outsourcing, advancements in academic translational research, constraints in in-house production capacities, and an escalating need for specialized bioprocessing solutions.
The cell and gene therapy manufacturing services market is poised for substantial expansion, projecting a reach of $21.05 billion by 2030, fueled by a robust compound annual growth rate (CAGR) of 17.4%. This anticipated surge in the upcoming forecast period is largely driven by the escalating commercialization of these advanced therapies, a heightened need for expansive manufacturing capabilities, the proliferation of individualized treatment options, greater regulatory certainty surrounding novel therapeutic approaches, and amplified financial commitments towards sophisticated therapy infrastructure. Key developments shaping this market moving forward include the broadening of Good Manufacturing Practice (GMP) compliant production facilities, increased utilization of automated cell processing equipment, growing demand for adaptable viral vector manufacturing solutions, the more widespread implementation of cutting-edge quality assurance technologies, and a heightened emphasis on harmonizing manufacturing processes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
Cell & Gene Therapy Manufacturing Services Market Demand Drivers: What Is Fueling Industry Growth?
Anticipate a surge in the cell and gene therapy manufacturing services sector, largely fueled by the elevated prevalence of cancer and other significant illnesses. Cancer, characterized by the rapid and uncontrolled proliferation of body cells leading to aberrant growth, presents a formidable health challenge. Emerging cell and gene therapies are offering considerable hope as innovative approaches to address the increasing rates of cancer, thereby spurring a greater need for advanced and effective therapeutic solutions. As an illustration, the American Cancer Society, a prominent US non-profit dedicated to cancer advocacy, projected in February 2025 that the United States would witness approximately 316,950 new diagnoses of invasive breast cancer among women and 2,800 among men in 2025. Consequently, the substantial burden of cancer and related diseases is set to be a primary driver for the expansion of the cell and gene therapy manufacturing services market.
Cell & Gene Therapy Manufacturing Services Market Segmentation And Category Breakdown
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Cell & Gene Therapy Manufacturing Services Market Innovation Trends: Which Developments Are Transforming The Industry?
Companies at the forefront of the cell and gene therapy manufacturing services sector are investing in novel biomanufacturing methods to boost the scalability, efficiency, and quality of cell and gene therapies. As an illustration, in September 2025, the U.S. government health entity ARPA-H initiated a project designed to spark groundbreaking biomanufacturing for cell and gene therapies, with the objective of speeding up the creation of sophisticated manufacturing platforms, increasing production outputs, and facilitating the cost-effective and scalable production of intricate cell and gene therapy products, and through its backing of technologies with high potential for significant breakthroughs, this endeavor is anticipated to foster advancements in biomanufacturing, reinforce the overall manufacturing infrastructure, and expedite patient access to life-changing treatments.
Cell & Gene Therapy Manufacturing Services Market Competitive Analysis Of Major Industry Participants
Major companies operating in the cell & gene therapy manufacturing services market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Fujifilm Holdings Corporation, Oxford Biomedica plc, Cell and Gene Therapy Catapult, Samsung Biologics Co. Ltd., BioNTech SE, Novartis International AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Sarepta Therapeutics Inc., bluebird bio Inc., Precision BioSciences Inc., GSK plc, AstraZeneca plc, Bayer AG
Access The Complete Cell & Gene Therapy Manufacturing Services Market Report:
Cell & Gene Therapy Manufacturing Services Market Geographic Landscape: Which Region Dominates Industry Growth?
North Americawas the largest region in the cell and gene therapy manufacturing services market in 2025.Asia-Pacificis expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
